Abstract:Cyclin-dependent kinases (CDKs), particularly CDK4 and CDK2, are crucial for cell cycle progression from the Gap 1 (G1) to the Synthesis (S) phase by phosphorylating targets such as the Retinoblastoma Protein (Rb). CDK4, paired with cyclin-D, operates in the long G1 phase, while CDK2 with cyclin-E, manages the brief G1-to-S transition, enabling DNA replication. Aberrant CDK signaling leads to uncontrolled cell proliferation, which is a hallmark of cancer. Exactly how they accomplish their catalytic phosphorylation actions with distinct efficiencies poses the fundamental, albeit overlooked question. Here we combined available experimental data and modeling of the active complexes to establish their conformational functional landscapes to explain how the two cyclin/CDK complexes differentially populate their catalytically competent states for cell cycle progression. Our premise is that CDK catalytic efficiencies could be more important for cell cycle progression than the cyclin-CDK biochemical binding specificity and that efficiency is likely the prime determinant of cell cycle progression. We observe that CDK4 is more dynamic than CDK2 in the ATP binding site, the regulatory spine, and the interaction with its cyclin partner. The N-terminus of cyclin-D acts as an allosteric regulator of the activation loop and the ATP-binding site in CDK4. Integrated with a suite of experimental data, we suggest that the CDK4 complex is less capable of remaining in the active catalytically competent conformation, and may have a lower catalytic efficiency than CDK2, befitting their cell cycle time scales, and point to critical residues and motifs that drive their differences. Our mechanistic landscape may apply broadly to kinases, and we propose two drug design strategies: (i) allosteric Inhibition by conformational stabilization for targeting allosteric CDK4 regulation by cyclin-D, and (ii) dynamic entropy-optimized targeting which leverages the dynamic, entropic aspects of CDK4 to optimize drug binding efficacy.

Hysteresis and Cell Cycle Transitions: How Crucial is It?

On the assembly of the mitotic spindle, bistability and hysteresis

Multisite Phosphorylation and Network Dynamics of Cyclin-Dependent Kinase Signaling in the Eukaryotic Cell Cycle.

The oscillation of mitotic kinase governs cell cycle latches in mammalian cells

The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition

Discrete differential geometry of triangle tiles and algebra of closed trajectories

Cell Cycle Progression Mechanisms: Slower Cyclin-D/cdk4 Activation and Faster Cyclin-E/cdk2.

From quiescence to proliferation: Cdk oscillations drive the mammalian cell cycle

Why minimal is not optimal: Driving the mammalian cell cycle—and drug discovery—with a physiologic CDK control network

Hysteresis in the cell response to time-dependent substrate stiffness

Quantitative Studies for Cell-Division Cycle Control

Cell Cycle Control by a Minimal Cdk Network

CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets

Hysteresis Control of Epithelial-Mesenchymal Transition Dynamics Conveys a Distinct Program with Enhanced Metastatic Ability

Newton′s Cradle: Cell Cycle Regulation by Two Mutually Inhibitory Oscillators

Slower CDK4 and faster CDK2 activation in the cell cycle

Nonequilibrium and nonlinear kinetics as key determinants for bistability in fission yeast G2-M transition

Phosphorylation energy and nonlinear kinetics as key determinants for G2/M transition in fission yeast cell cycle

Newton's cradle: Cell cycle regulation by two mutually inhibitory oscillators

Core control principles of the eukaryotic cell cycle

A Mathematical Model for Cell Cycle Control: Graded Response or Quantized Response.